APBs are crucial for the [survival of ALT-positive cancer cells](#). These cells are often resistant to telomerase inhibitors, making them challenging targets for conventional therapies. Understanding APBs can lead to the development of novel therapies aimed at disrupting the ALT pathway, thereby inhibiting the growth of these resistant cancer cells.
